AFC Gamma Q2 Earnings Call Highlights
AFC Gamma (NASDAQ:AFCG) reported Q2 earnings call highlights. It said originations may be lumpy, with about $80M in Q1 originations and less in Q2. As of June 30, fair value was $290M across 17 companies, weighted average yield 13.2%. Q2 investment income was $8.7M. NAV per share rose to $8.25; it repurchased ~839k shares at $3.29. DEBI liquidation term sheet targets $12.5M cash proceeds.
How this was made

The 30-second read
Why it matters
Traders can update expectations for near-term earnings power based on investment income trends, portfolio yield, and the timing of cash proceeds from legacy cannabis workouts.
Market read
Sequential NAV per share increased to $8.25 and liquidity remains available, but lower Q2 originations and ongoing legacy cannabis resolution risk keep the outlook balanced.
What to watch
Liquidity and co-investment relief may support future deployment, but the key swing factor is the pace and certainty of DEBI and other cannabis asset resolutions.
Background
The piece summarizes AFC Gamma’s Q2 earnings call, covering portfolio composition, originations, legacy cannabis loan resolutions, and capital allocation.
Ticker impact
AFC Gamma reported Q2 call details including $8.7M investment income, NAV per share rising to $8.25, and $2.8M share repurchases at $3.29.
Near-term trading likely muted unless investors focus on originations lumpy commentary and legacy cannabis resolution timelines.
The article provides specific portfolio, income, NAV, and liquidity/repurchase figures, but no new guidance or surprise event beyond the quarter’s disclosed metrics.
Market effects
Highlights typical specialty finance REIT drivers: originations timing, portfolio yield, and legacy credit resolution risk.
Behavioral health platform commitment is Northeast-focused, but scale is small versus broader REIT market.
Limited, as disclosures are company-specific and not tied to global macro shocks.
Counterpoint
NAV rose, but originations were lower in Q2 and legacy cannabis remains concentrated in non-accrual assets, which can cap risk appetite.
Key entities
- public_companyAFC Gamma, Inc.
Specialty finance REIT focused on structured financing secured by real assets and contractual revenue streams.
- credit_instrumentDEBI (legacy cannabis loan)
Receiver-led liquidation process with term sheet to sell additional assets for $12.5M cash proceeds, expected to close this year.
- credit_instrumentDMA (legacy cannabis loan)
Receiver sold two of three dispensaries after regulatory approvals; one asset remains unresolved.
- credit_instrumentJustice Grown loan
Matured May 1 and is in maturity default; AFC commenced Article 9 foreclosure actions and is pursuing remedies including guarantees.




